This ability to inhibit tumor cell migration and invasion was confirmed in a mouse xenograft model.[45] In recent years, the emerging appearance of CTSS small molecule inhibitors and monoclonal antibodies with highly selective targeting to inhibit the proteolytic effect of CTSS provides new ways and directions for tumor treatments.[46,47]. The gene discussed is CTSS; the disease is neoplasm.